Czechia – Antineoplastic agents – Léčivé přípravky s obsahem lenvatinibu
Original notice title
Léčivé přípravky s obsahem lenvatinibu
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
30 / 100
Risk factors
The procurement documents (Zadávací dokumentace) are referenced but were not extracted or analyzed. These documents lik...
Lot 2 has a missing title and currency field was null in structured data. While XML notice implies CZK, the lack of exp...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- CZK 136.6M estimated value
- Supplies contract
- 2 lots
- Continuous supply of lenvatinib-containing medicinal products (antineoplastic agents) for a period of 4 years
- Supplies are delivered as per the buyer's current needs (periodic deliveries)
Show full summary
This tender is an open procedure for the supply of lenvatinib-containing medicinal products to Fakultní nemocnice Hradec Králové over a 4-year period. The tender is divided into two lots (část 1 and část 2), both with the same CPV code (33652100) and place of performance (CZ052, Czech Republic). The estimated total value is 136,632,000 CZK, comprising 127,220,000 CZK for Lot 1 and 9,412,000 CZK for Lot 2. Submission is electronic via the buyer's profile, with a deadline of 2026-07-13T08:00:00.000Z. Award is based on lowest price. Procurement documents (Zadávací dokumentace) are available but were not analyzed.
Risks
The procurement documents (Zadávací dokumentace) are referenced but were not extracted or analyzed. These documents lik...
Lot 2 has a missing title and currency field was null in structured data. While XML notice implies CZK, the lack of exp...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Open procedure
Administrative
- Electronic submission required via the buyer's e-procurement system
- Submission language: Czech (CES)
Award Criteria
Lot 1
Lot 2
Buyer
Name
Fakultní nemocnice Hradec Králové
Location
Hradec Králové - Nový Hradec Králové, CZE
Website
Buyer profile
Identifier
00179906
Lots (2)
LOT-0012
část 1
Continuous supply of lenvatinib medicinal products for 4 years under the same terms as the overall tender.
CZK 127.2M
Estimated value
Location
Category
Deadline
Award details
Value note
Show original TED data
Original TED description
Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem lenvatinibu po dobu 4 let dle aktuálních potřeb zadavatele.
LOT-0014
část 2
Continuous supply of lenvatinib medicinal products for 4 years under the same terms as the overall tender. Lot title and full description are missing; inferred from lot identifier and internal identifier.
CZK 9.4M
Estimated value
Location
Category
Deadline
Value note
Procurement Details
- Publication date
- 11 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Czech
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 404819-2026
- Source notice ID
- 9380e74b-284a-410c-8ba9-98f3d71b06c2
Documents (1)
Similar tenders
Poland – Antineoplastic agents – Dostawa produktów leczniczych i wyrobów medycznych do Wojskowego Instytutu Medycznego – PIB
Poland – Antineoplastic agents – Leki onkologiczne i sprzęt pomocniczy
Romania – Antineoplastic agents – achizitia de medicamente utilizate in tratamentul pacientilor beneficiari ai Programului Programului national de oncologie-Subprogramul de tratament medicamentos al bolnavilor cu afectiuni oncologice (adulti si copii), Programul national de oncologie medicamente COST-VOLUM
Poland – Pharmaceutical products – Przetarg uzupełniający na dostawę do WCSKJ produktów leczniczych stosowanych w programach lekowych i chemioterapii
Czechia – Antineoplastic agents – Léčivé přípravky s obsahem antineoplastik
Romania – General anti-infectives for systemic use and vaccines – Achizitie Medicamente 1 - 2026
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
30 / 100
Risk factors
The procurement documents (Zadávací dokumentace) are referenced but were not extracted or analyzed. These documents lik...
Lot 2 has a missing title and currency field was null in structured data. While XML notice implies CZK, the lack of exp...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications